Top January 2023 FDA Approvals
January FDA approvals include treatments for mood disorders, pertussis in infants, Alzheimer disease, and type 2 diabetes.
General Medicine
Top December 2022 FDA Approvals
December FDA approvals include treatments for weight loss in adolescents, major depressive disorder, lung cancer detection, metastatic non-small cell lung cancer, multiple sclerosis, and lymphoma.
What Happened to Provider Communication Etiquette?
Nurse practitioner experiences poor provider etiquette when making medical decisions for her father who was hospitalized following COVID-19 infection.
Medicine vs Food: the Patient Care Dilemma of ‘Financial Toxicity’
Experts are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
How the Pandemic Widened America’s Health Care Gap — and How We Can Close It
Dr Fayanju discusses strategies for health care providers and federal lawmakers to help close equity gaps in American health care.
Why Is It So Hard for Me to See My PCP?
Jim Anderson, PA-C, wonders why it is so difficult to see his primary care provider. Is it pandemic related or is something else broken in health care?
Nurse-Lead Mobile Health Care Clinic to Serve Vulnerable Communities
The nurse-led mobile clinic will provide high-quality, evidence-based health care to underserved communities.
Red Eye: Common Ophthalmologic Disorders in Primary Care
Recognize the signs and symptoms of red eye that differentiate benign from vision-threatening ophthalmologic illnesses.
DEA: “Rainbow Fentanyl” a Deliberate Tactic to Target Young People
Brightly colored versions of the synthetic opioid fentanyl are appearing across the US, according to the Drug Enforcement Administration.
Opioid Denials Lead to Rise in Violent Attacks on Pain and Addiction Experts
Pain and addiction specialists discuss the rise in workplace violence over opioid denials and how to improve communication and change patient expectations.
Latest News
Jesduvroq Approved for Anemia of CKD in Patients on Dialysis
Maker of Weight-Loss Drug Wegovy Ramps Up Production to Meet Demand
Trends in Chronic Pain and Its Management Among Nursing Home Residents With Dementia
FDA Revises Paxlovid, Lagevrio EUAs Removing Positive COVID-19 Test Requirement
FDA Issues Warning to Companies Selling Products Claiming to Treat Mpox
Amjevita, a Biosimilar to Humira, Now Available
More Support and Critique of AAP Guideline for Childhood Obesity
Supervised Aerobic Exercise Cuts Long-Term Diabetes Risk With Obesity
Indiana’s Health Care Access Crisis: Are APRNs the Answer?
Obesity Organizations Release Consensus Statement
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in General Medicine
Loading... 
Loading...